Skip to Content
Merck
  • Translating the concept of peptide labeling with 5-deoxy-5-[18F]fluororibose into preclinical practice: 18F-labeling of Siglec-9 peptide for PET imaging of inflammation.

Translating the concept of peptide labeling with 5-deoxy-5-[18F]fluororibose into preclinical practice: 18F-labeling of Siglec-9 peptide for PET imaging of inflammation.

Chemical communications (Cambridge, England) (2013-03-29)
Xiang-Guo Li, Anu Autio, Helena Ahtinen, Kerttuli Helariutta, Heidi Liljenbäck, Sirpa Jalkanen, Anne Roivainen, Anu J Airaksinen
ABSTRACT

Peptide glycosylation with 5-deoxy-5-[(18)F]fluororibose was translated into preclinical settings. The novel (18)F-labeled Siglec-9 peptide was produced using an automated synthesis procedure. The (18)F-labeled Siglec-9 peptide showed favorable binding in the animal model of inflammation in vivo.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
D-(−)-Ribose, 98%
Sigma-Aldrich
D-(−)-Ribose, ≥98%
Sigma-Aldrich
D-(−)-Ribose, suitable for cell culture, BioReagent
Sigma-Aldrich
D-(−)-Ribose, ≥99% (GC)